This finding is in line with the results reported by Hu XY et al. on acute leukemia patients, which suggested that autophagy activation and expression of BECN1 and MAP1LC3B genes were significantly higher in de novo patients as compared to the controls (Hu et al., 2011). This evidence concerns the gene MAP1LC3B and acute leukemia.